PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing Scheme with Express Scripts, Inc.

Policy & Medicine
Written By St. Paul Corner Drug (SPCD)

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and Blue Shield Plans, was found guilty of engaging in horizontal price-fixing in collaboration with Express Scripts, Inc. (ESI), a competitor owned by Cigna.

St. Paul Corner Drug (SPCD)
Previous

'Knock out the middlemen' is a campaign promise Donald Trump should keep
Next

Colliers releases The Changing Retail Pharmacy Landscape report